Foto: Balticnews
Latvian pharmaceutical manufacturer Olpha has signed a cooperation agreement with Switzerland-based international pharmaceutical company Adalvo to introduce a new medicine for the treatment of type 2 diabetes and weight management in the Baltic markets. The partnership will expand Olpha’s diabetes treatment portfolio. The agreement was signed at the CPHI Milan pharmaceutical industry exhibition in early […]
